If a patient on semaglutide 2.4 mg (Wegovy) has not met that threshold after 16 weeks, switching to tirzepatide is a reasonable next step supported by that guideline framework
A little snippy for no reason
Dehydration/Kidney Risk: Due to the risk of nausea and vomiting, patients are at higher risk for dehydration, which can lead to acute kidney injurya critical safety point not mentioned here
Purpose: Saxenda is primarily used for weight loss, while Ozempic is mainly used for diabetes, which can also lead to weight loss
The monthly fee does not include the cost of medication
Efficacy and Safety of Liraglutide and Semaglutide on Weight Loss in People with Obesity or Overweight: A Systematic Review Joseph Azuri, Ariel Hammerman, Enis Aboalhasan, Ben Sluckis, Ronen Arbel (2023)